NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 263 filers reported holding NOVOCURE LTD in Q2 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $286,433 | -18.2% | 6,902 | +18.6% | 0.00% | – |
| Q1 2023 | $349,954 | -33.8% | 5,819 | -19.3% | 0.00% | – |
| Q4 2022 | $528,780 | +10.6% | 7,209 | +14.4% | 0.00% | – |
| Q3 2022 | $478,000 | +32.8% | 6,300 | +22.0% | 0.00% | – |
| Q2 2022 | $360,000 | -10.4% | 5,165 | +6.4% | 0.00% | – |
| Q1 2022 | $402,000 | +33.6% | 4,853 | +21.3% | 0.00% | – |
| Q4 2021 | $301,000 | -43.0% | 4,002 | -12.1% | 0.00% | – |
| Q3 2021 | $528,000 | -54.9% | 4,553 | -13.6% | 0.00% | – |
| Q2 2021 | $1,170,000 | -2.9% | 5,271 | -42.2% | 0.00% | – |
| Q1 2021 | $1,205,000 | -93.3% | 9,113 | -91.2% | 0.00% | -100.0% |
| Q4 2020 | $17,928,000 | +7561.5% | 103,609 | +4822.0% | 0.01% | – |
| Q3 2020 | $234,000 | – | 2,105 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
| MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
| Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
| Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
| Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
| Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
| Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |